Nanjing Leads Biolabs Co., Ltd.
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Nanjing ranks #41,846 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 5 technology areas.
- #41,846
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (41.3/100)
- 22.2
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R41846 · Foreign Corporation #41,846 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 6 grants
- LOWER-Q #41,846/49,997
- PHOTO-FINISH Nachurs Alpine…
- CPC-NARROW A61P · 5 areas
- INNOV-PAR 41.3/100
- CLAIMS-DENSE 22.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2024 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Nachurs Alpine Solutions, Corp. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Nanjing’s 41.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Nanjing
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Nanjing Leads Biolabs · this assignee
Nanjing Leads Biolabs · this assignee
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Nanjing's Innovation Score is 41.3/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Nanjing?
Each dot is one of Nanjing’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Nanjing’s own 22.2 claims/patent is ABOVE the 11.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Nanjing's grants concentrate
Nanjing Leads Biolabs Co., Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2020. By volume, Nanjing sits between Nachurs Alpine Solutions, Corp. and Nano Safe Coatings Incorporated.
Nanjing's three-year grant acceleration
Nanjing Leads Biolabs Co., Ltd. shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Nanjing's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Nachurs Alpine So…
Nachurs Alpine Solutions, Corp.
6 patents
- Najit
Najit Technologies, Inc.
6 patents
- Naked Labs Austria
Naked Labs Austria GMBH
6 patents
- Nanjing Greenchip…
Nanjing Greenchip Semiconductor Co., Ltd.
6 patents
- Nanjingjinsirui S…
Nanjingjinsirui Science & Technology Biology Corp.
6 patents
- Nano Evaporative
Nano Evaporative Technologies, Inc.
6 patents
- Nano Hesgarsazan…
Nano Hesgarsazan Salamat Arya
6 patents
- Nano Safe Coating…
Nano Safe Coatings Incorporated
6 patents
- Nanjing Leads Bio… ◀
Nanjing Leads Biolabs Co., Ltd.
6 patents
What this shows Nanjing holds 6 patents at rank #41,934, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Nanjing
By rank, the assignees closest to #41,934 in granted patent volume.
- Nachurs Alpine Solutions, Corp. #41,930 · 6 patents
- Najit Technologies, Inc. #41,931 · 6 patents
- Naked Labs Austria GMBH #41,932 · 6 patents
- Nanjing Greenchip Semiconductor Co., Ltd. #41,933 · 6 patents
- Nanjingjinsirui Science & Technology Biology Corp. #41,935 · 6 patents
- Nano Evaporative Technologies, Inc. #41,936 · 6 patents
- Nano Hesgarsazan Salamat Arya #41,937 · 6 patents
- Nano Safe Coatings Incorporated #41,938 · 6 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Nanjing's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Nanjing's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 2 | 33.3% |
| 2024 | 1 | 16.7% |
Which technologies does Nanjing Leads Biolabs Co., Ltd. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Nanjing Leads Biolabs Co., Ltd.'s patent record in context - here's where to go next.
- Nanjing Leads Biolabs Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #41,846 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Nanjing Leads Biolabs Co., Ltd. against Nachurs Alpine Solutions, Corp., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 41.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.